Show simple item record

dc.contributor.authorGullick, D.R.
dc.contributor.authorIngram, M.J.
dc.contributor.authorPugh, W.J.
dc.contributor.authorCox, P.A.
dc.contributor.authorGard, P.
dc.contributor.authorSmart, J.D.
dc.contributor.authorMoss, G.P.
dc.identifier.citationGullick , D R , Ingram , M J , Pugh , W J , Cox , P A , Gard , P , Smart , J D & Moss , G P 2009 , ' Metabolism of captopril carboxyl ester derivatives for percutaneous absorption ' , Journal of Pharmacy and Pharmacology , vol. 61 , no. 2 , pp. 159-165 .
dc.identifier.otherPURE: 185628
dc.identifier.otherPURE UUID: 754d74d2-8dc9-49c3-85df-7200a00b0879
dc.identifier.otherdspace: 2299/4840
dc.identifier.otherScopus: 59049099239
dc.descriptionOriginal article can be found at: Copyright Pharmaceutical Press [Full text of this article is not available in the UHRA]
dc.description.abstractTo determine the metabolism of captopril n-carboxyl derivatives and how this may impact on their use as transdermal prodrugs. The pharmacological activity of the ester derivatives was also characterised in order to compare the angiotensin converting enzyme inhibitory potency of the derivatives compared with the parent drug, captopril.en
dc.relation.ispartofJournal of Pharmacy and Pharmacology
dc.titleMetabolism of captopril carboxyl ester derivatives for percutaneous absorptionen
dc.contributor.institutionDepartment of Pharmacy
dc.description.statusPeer reviewed
rioxxterms.typeJournal Article/Review

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record